All In Biotech

Drug Trial Radar · NCT06058013

Study to Assess the Effects of Oral NMRA-335140 Versus Placebo in Participants With Major Depressive Disorder

A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effects of Oral NMRA-335140 Versus Placebo in Participants With Major Depressive Disorder

Last checked: Nov 20, 2026Latest source record: Jul 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 430 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

430

Actual

Start

Dec 20, 2023

Primary completion

May 6, 2026

Study completion Jun 17, 2026

Sponsor

Lead sponsor
Neumora Therapeutics, Inc.Industry
Sponsor type
Industry
First posted
Sep 28, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a randomized, double-blind, placebo-controlled, multicenter study to evaluate the effects of NMRA-335140 (formerly BTRX-335140) on symptoms of depression in participants with Major Depressive Disorder (MDD). The study design consists of a Screening Period (up to 28 days), and a 6-week Treatment Period (during which participants will receive either NMRA-335140 or placebo). At the completion of the 6-week Treatment Period, participants who complete the study, provide informed consent, and meet the eligibility criteria may enter an open-label extension study (NMRA-335140-501).

Conditions

  • Major Depressive Disorder

Interventions

  • NMRA-335140Drug

    Participants will receive NMRA-335140 at a dose of 80 mg QD, orally

  • PlaceboDrug

    Placebo will be administered orally

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change from Baseline to Week 6 in the Montgomery-Asberg Depression Rating Scale (MADRS) total scoreTime frame: Baseline and up to Week 6

Locations

74 sites in 4 countries. Site status is shown where the registry gives one.

  • Neumora Investigator Site

    Encino, California

  • Neumora Investigator Site

    Garden Grove, California

  • Neumora Investigator Site

    Los Alamitos, California

  • Neumora Investigator Site

    Newport Beach, California

  • Neumora Investigator Site

    Orange, California

  • Neumora Investigator Site

    Santa Ana, California

  • Neumora Investigator Site

    Norwalk, Connecticut

  • Neumora Investigator Site

    Bradenton, Florida

  • Neumora Investigator Site

    Hollywood, Florida

  • Neumora Investigator Site

    Homestead, Florida

  • Neumora Investigator Site

    Lauderhill, Florida

  • Neumora Investigator Site

    Maitland, Florida

  • Neumora Investigator Sites

    Miami, Florida

  • Neumora Investigator Site

    Miami, Florida

  • Neumora Investigator Site

    Miami, Florida

  • Neumora Investigator Site

    Miami, Florida

  • Neumora Investigator Site

    Miami, Florida

  • Neumora Investigator Site

    Miami Lakes, Florida

  • Neumora Investigator Site

    Miami Lakes, Florida

  • Neumora Investigator Site

    Orlando, Florida

  • Neumora Investigator Site

    Orlando, Florida

  • Neumora Investigator Site

    Orlando, Florida

  • Neumora Investigator Site

    Pinellas Park, Florida

  • Neumora Investigator Site

    Pompano Beach, Florida

  • Neumora Investigator Site

    Tampa, Florida

  • Neumora Investigator Site#1

    Tampa, Florida

  • Neumora Investigator Site

    Tampa, Florida

  • Neumora Investigator Site

    Atlanta, Georgia

  • Neumora Investigator Site

    Atlanta, Georgia

  • Neumora Investigator Site

    Atlanta, Georgia

  • Neumora Investigator Site

    Marrero, Louisiana

  • Neumora Investigator Site

    New Orleans, Louisiana

  • Neumora Investigator Site

    Baltimore, Maryland

  • Neumora Investigator Site

    Towson, Maryland

  • Neumora Investigator Site

    Boston, Massachusetts

  • Neumora Investigator Site

    Boston, Massachusetts

  • Neumora Investigator Site

    Watertown, Massachusetts

  • Neumora Investigator Site

    Mankato, Minnesota

  • Neumora Investigator Site

    Princeton, New Jersey

  • Neumora Investigator Site

    Toms River, New Jersey

Showing 40 of 74 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.